Royalty Pharma Reports Second Quarter 2023 Results
Go back to Royalty Pharma Reports Second Quarter 2023 Results| REPROS THERAPEUTICS (NASDAQ: RPRX) | Delayed: 61.07 +0.49 (0.81%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $60.58 | 52 Week High | $3.48 | |||
| Open | $60.53 | 52 Week Low | $0.80 | |||
| Day High | $61.46 | P/E | N/A | |||
| Day Low | $60.37 | EPS | $-1.54 | |||
| Volume | 892,619 | |||||

